Dolan P Modeling valuations for EuroQol health states. Med Care. 1997 Nov;35(11):1095-108.
Eaton T, Young P, Nicol K, Kolbe J The endurance shuttle walking test: a responsive measure in pulmonary rehabilitation for COPD patients. Chron Respir Dis. 2006;3(1):3-9.
EuroQol Group EuroQol--a new facility for the measurement of health-related quality of life. Health Policy. 1990 Dec;16(3):199-208.
Foglio K, Bianchi L, Ambrosino N Is it really useful to repeat outpatient pulmonary rehabilitation programs in patients with chronic airway obstruction? A 2-year controlled study. Chest. 2001 Jun;119(6):1696-704.
Garrod R, Ansley P, Canavan J, Jewell A Exercise and the inflammatory response in chronic obstructive pulmonary disease (COPD)--Does training confer anti-inflammatory properties in COPD? Med Hypotheses. 2007;68(2):291-8. Epub 2006 Sep 28. Review.
Hui KP, Hewitt AB A simple pulmonary rehabilitation program improves health outcomes and reduces hospital utilization in patients with COPD. Chest. 2003 Jul;124(1):94-7.
Lacasse Y, Martin S, Lasserson TJ, Goldstein RS Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. A Cochrane systematic review. Eura Medicophys. 2007 Dec;43(4):475-85. Review.
Moullec G, Ninot G, Varray A, Desplan J, Hayot M, Prefaut C An innovative maintenance follow-up program after a first inpatient pulmonary rehabilitation. Respir Med. 2008 Apr;102(4):556-66. doi: 10.1016/j.rmed.2007.11.012. Epub 2007 Dec 27.
Norweg AM, Whiteson J, Malgady R, Mola A, Rey M The effectiveness of different combinations of pulmonary rehabilitation program components: a randomized controlled trial. Chest. 2005 Aug;128(2):663-72.
Puhan MA, Schünemann HJ, Frey M, Scharplatz M, Bachmann LM How should COPD patients exercise during respiratory rehabilitation? Comparison of exercise modalities and intensities to treat skeletal muscle dysfunction. Thorax. 2005 May;60(5):367-75. Review.
Redelmeier DA, Guyatt GH, Goldstein RS Assessing the minimal important difference in symptoms: a comparison of two techniques. J Clin Epidemiol. 1996 Nov;49(11):1215-9.
Ries AL, Kaplan RM, Myers R, Prewitt LM Maintenance after pulmonary rehabilitation in chronic lung disease: a randomized trial. Am J Respir Crit Care Med. 2003 Mar 15;167(6):880-8. Epub 2002 Dec 27.
Singh SJ, Morgan MD, Hardman AE, Rowe C, Bardsley PA Comparison of oxygen uptake during a conventional treadmill test and the shuttle walking test in chronic airflow limitation. Eur Respir J. 1994 Nov;7(11):2016-20.
Singh SJ, Smith DL, Hyland ME, Morgan MD A short outpatient pulmonary rehabilitation programme: immediate and longer-term effects on exercise performance and quality of life. Respir Med. 1998 Sep;92(9):1146-54.
Singh SJ, Sodergren SC, Hyland ME, Williams J, Morgan MD A comparison of three disease-specific and two generic health-status measures to evaluate the outcome of pulmonary rehabilitation in COPD. Respir Med. 2001 Jan;95(1):71-7.
Steiner MC, Barton RL, Singh SJ, Morgan MD Bedside methods versus dual energy X-ray absorptiometry for body composition measurement in COPD. Eur Respir J. 2002 Apr;19(4):626-31.
Williams JE, Singh SJ, Sewell L, Morgan MD Health status measurement: sensitivity of the self-reported Chronic Respiratory Questionnaire (CRQ-SR) in pulmonary rehabilitation. Thorax. 2003 Jun;58(6):515-8.
The Effects of Maintenance Schedules Following Pulmonary Rehabilitation in Patients With Chronic Obstructive Pulmonary Disease
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.